-
-
-
-
-
-
-
VolitionRx receives NYSE American approval for compliance plan
-
-
-
-
-
-
-
Volition reports 95% detection rate for early-stage cancers
-
-
-
-
-
-
-
VolitionRx receives first clinical order for cancer test
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on VolitionRX (VNRX)
-
-
-
-
-
-
-
Benchmark Reiterates Hold Rating on VolitionRX (VNRX)
-
-
-
-
-
-
-
Volitionrx Limited (VNRX) Appoints Ethel Rubin to its Board
-
416,808 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

